Select a Team Member
Select the team member who asked for your support in the fight to beat rare cancers. If you prefer to give to the team and not a specific team member, please click “Donate to Team” below.
100% of all donations support research led by MSK.
- OR -Donate to Team
JOIN THE BATTLE. Beat Rare Cancers.
WELCOME TO TEAM MORSE-DAVIS!
It seems uncommon to find a family that cancer has not impacted in some way. We are riding and raising money for Cycle for Survival, the movement to beat rare cancers because cancer has affected our families and we don't want it to happen to other families. 100% of every dollar funds innovative studies and clinical trials led by Memorial Sloan Kettering Cancer Center (MSK). Discoveries made by MSK revolutionize how cancer is diagnosed and treated, benefitting patients everywhere.
Your gift will help give people with rare cancers a better future through new and improved treatments. Since 2007, Cycle for Survival supporters have provided resources to hundreds of doctors and scientists to pursue bold ideas that have led to the FDA approval of new drugs, lifesaving clinical trials, and four state-of-the-art DNA sequencers that are aiding in key cancer discoveries.
On February 8th, Team Morse-Davis will hop on our three bikes, let the music pump through our veins, and ride our hearts out for our family members. We will be riding for our Vicki, our Andrew, and our Gramps, and to help Memorial Sloan Kettering make sure cancer isn’t this cruel to another family.
Thank you for supporting us!
|The Cycle for Survival Web page and e-mail are provided as a courtesy to participants to help them manage fundraising efforts for this event. Memorial Sloan Kettering Cancer Center or any of its affiliated organizations, or their officers, directors, agents, or employees do not control, nor are they responsible for, the contents of this Web page. Any views or information provided on this Web page are the sole responsibility of the participant.
The participant's Web page may provide links to other Web sites and does not imply an endorsement by MSKCC, its affiliated organizations, their officers, directors, agents, and employees of the materials contained at those Web sites.
If you think this page contains objectionable content, please inform the system administrator.